Eiger BioPharmaceuticals, Inc.
EIGRQ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$75 | -$97 | -$34 | -$65 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $8 | $8 | $6 |
| Change in WC | -$6 | $0 | -$1 | -$6 |
| Other Non-Cash | $12 | $14 | -$34 | $10 |
| Operating Cash Flow | -$75 | -$83 | -$72 | -$63 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$49 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$19 | -$75 | -$85 | -$128 |
| Inv. Sales/Matur. | $94 | $85 | $100 | $84 |
| Other Inv. Act. | $74 | $10 | $95 | -$45 |
| Investing Cash Flow | $74 | $10 | $62 | -$45 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $7 | $0 | $0 |
| Stock Issued | $0 | $71 | $3 | $97 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$1 | $0 | $1 |
| Financing Cash Flow | $0 | $77 | $3 | $97 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$0 | $4 | -$7 | -$11 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $26 | $22 | $29 | $39 |
| End Cash | $25 | $26 | $22 | $29 |
| Free Cash Flow | -$75 | -$83 | -$120 | -$63 |